milgamma protekt Uses, Dosage, Side Effects and more
milgamma protekt has been investigated for the treatment and prevention of Diabetic Nephropathy and Diabetes Mellitus, Type 2.
| Attribute | Details |
|---|---|
| Trade Name | milgamma protekt |
| Generic | Benfotiamine |
| Benfotiamine Other Names | Benfotiamina, Benfotiamine, Benphothiamine, Benzoylthiamine monophosphate, S-benzoylthiamine monophosphate |
| Type | |
| Formula | C19H23N4O6PS |
| Weight | Average: 466.45 Monoisotopic: 466.107592649 |
| Groups | Approved, Experimental |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | Bulgaria, Germany |
| Last Updated: | January 7, 2025 at 1:49 am |
Uses
milgamma protekt is a derivative of thiamine thought to be useful in the management of diabetic neuropathy, although evidence is lacking.
milgamma protekt is also used to associated treatment for these conditions: Thiamine Deficiency
